These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21782133)

  • 1. Proteinuria in special populations: pregnant women and children.
    Hladunewich MA; Schaefer F
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):267-72. PubMed ID: 21782133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REIN on obesity, proteinuria and CKD.
    Choi ME
    J Am Soc Nephrol; 2011 Jun; 22(6):990-2. PubMed ID: 21617125
    [No Abstract]   [Full Text] [Related]  

  • 3. Pre-eclampsia and the kidney.
    Mirza FG; Cleary KL
    Semin Perinatol; 2009 Jun; 33(3):173-8. PubMed ID: 19464508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pentoxifylline on GFR decline in CKD: a pilot, double-blind, randomized, placebo-controlled trial.
    Perkins RM; Aboudara MC; Uy AL; Olson SW; Cushner HM; Yuan CM
    Am J Kidney Dis; 2009 Apr; 53(4):606-16. PubMed ID: 19216016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of stopping inhibitors of the renin-angiotensin system in patients with advanced chronic kidney disease.
    Ahmed AK; Kamath NS; El Kossi M; El Nahas AM
    Nephrol Dial Transplant; 2010 Dec; 25(12):3977-82. PubMed ID: 19820248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin receptor blocker reduces proteinuria independently of blood pressure in children already treated with Angiotensin-converting enzyme inhibitors.
    Seeman T; Pohl M; Misselwitz J; John U
    Kidney Blood Press Res; 2009; 32(6):440-4. PubMed ID: 20016211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ramipril in the treatment of hypertension and proteinuria in children with chronic kidney diseases.
    Seeman T; Dusek J; Vondrák K; Flögelová H; Geier P; Janda J
    Am J Hypertens; 2004 May; 17(5 Pt 1):415-20. PubMed ID: 15110900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The use of angiotensin-converting enzyme inhibitors in chronic diffuse kidney diseases].
    Kutyrina IM; Tareeva IE; Gerasimenko OI; Rogov VA; Miroshnichenko NG
    Ter Arkh; 1995; 67(5):20-3. PubMed ID: 7638769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive versus conventional therapy to slow the progression of idiopathic glomerular diseases.
    Bianchi S; Bigazzi R; Campese VM
    Am J Kidney Dis; 2010 Apr; 55(4):671-81. PubMed ID: 20097461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteinuria: clinical signficance and basis for therapy.
    Woo KT; Lau YK
    Singapore Med J; 2001 Aug; 42(8):385-9. PubMed ID: 11764058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of proteinuria: CKD progression and cardiovascular outcomes.
    Sarnak MJ; Astor BC
    Adv Chronic Kidney Dis; 2011 Jul; 18(4):258-66. PubMed ID: 21782132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Progression of renal dysfunction. Possibilities of nephroprotection with ACE inhibitors].
    Schollmeyer P; Lehnert T; Böhler J
    Internist (Berl); 1992 Aug; 33 Suppl 1():S46-52. PubMed ID: 1428698
    [No Abstract]   [Full Text] [Related]  

  • 14. [The dynamic importance of proteinuria and arterial pressure for detecting late toxicosis in pregnant women with chronic kidney diseases and hypertension].
    Rogov VA; Zozulia OV; Tareeva IE; Sidorova IS; Makarov IO; Zhuravlev AV; Shipkova TI; Gertner LK; Beĭlin AL; Belitskaia SG
    Ter Arkh; 1995; 67(5):24-7. PubMed ID: 7638770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of proteinuria in defining pre-eclampsia: clinical outcomes for women and babies.
    Thornton CE; Makris A; Ogle RF; Tooher JM; Hennessy A
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):466-70. PubMed ID: 19930427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selectivity of glomerular proteinuria and liver function in gestosis].
    Kaltenbach FJ; Wilhelm C
    Zentralbl Gynakol; 1994; 116(6):340-3. PubMed ID: 8048289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial.
    Minutolo R; Gabbai FB; Borrelli S; Scigliano R; Trucillo P; Baldanza D; Laurino S; Mascia S; Conte G; De Nicola L
    Am J Kidney Dis; 2007 Dec; 50(6):908-17. PubMed ID: 18037091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antihypertensive treatment and glomerular size selectivity in hypertensive patients with renal parenchymal disease and proteinuria.
    Shand BI; Lewis JG; Elder PA; Agarwal M
    Clin Nephrol; 2002 Oct; 58(4):321-4. PubMed ID: 12400851
    [No Abstract]   [Full Text] [Related]  

  • 19. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteinuria after conversion to sirolimus in kidney transplant recipients: impact of pre-existing proteinuria, graft function, and angiotensin-converting enzyme inhibitors/angiotensin-receptor antagonists.
    Marx C; Busch M; Ott U; Gerth J; Wolf G
    Clin Transplant; 2010; 24(5):626-30. PubMed ID: 19925471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.